{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T05:24:48Z","timestamp":1772342688953,"version":"3.50.1"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T00:00:00Z","timestamp":1732665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Regulatory T (Treg) cells play a strategic role in maintaining immune homeostasis and their functions are closely linked to the development of different diseases, including cancer. This study aims to investigate the evolution patterns and popular research topics of Treg cells through bibliometric analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>The Web of Science Core Collection database was used to extract publications related to Treg cells, which were then subjected to bibliometric analysis and visualization through VOSviewer, CiteSpace, and R software.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Between 2003 and 2023, a total of 666 articles were published. China and the United States had the highest citation counts, with Fudan University, Shanghai Jiao Tong University, and Tarbiat Modares University being the leading research institutions. Beckhove Philipp from the German Cancer Research Center and the National Center for Tumor Diseases in Heidelberg, and Christophe from the Cancer Research Center of Lyon, were the most prolific authors. Sakaguchi Shimon from the Immunology Frontier Research Center at Osaka University was the most cited author. \u201cFrontiers in Immunology\u201d published the most articles, while \u201cJournal of Immunology\u201d received the highest co-citations. Key terms in Treg research include immunotherapy, tumor microenvironment, prognosis, immunosuppression, and PD-L1. Among these, immunotherapy, prognosis, PD-L1, and immunosuppression have emerged as focal points of research in recent years.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>With active collaboration worldwide, research on Treg cells is rapidly advancing. Focusing on Treg cells as a potential target for cancer treatment shows great promise for future research, especially in terms of practical applications. This could offer valuable direction and fresh perspectives for further exploration of Treg cells in the medical field.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2024.1448714","type":"journal-article","created":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T06:33:23Z","timestamp":1732689203000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Knowledge landscape of Treg research in breast cancer: a bibliometric and visual analysis"],"prefix":"10.3389","volume":"14","author":[{"given":"Zankai","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiping","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,11,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1756-8722-1-16","article-title":"Novel therapies in breast cancer: what is new from ASCO 2008","volume":"1","author":"Chu","year":"2008","journal-title":"J Hematol Oncol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.critrevonc.2007.09.001","article-title":"Impact of aging on the biology of breast cancer","volume":"66","author":"Benz","year":"2008","journal-title":"Crit Rev oncology\/hematology."},{"key":"B3","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1677\/erc.1.00758","article-title":"Stable \u2018portrait\u2019 of breast tumors during progression: data from biology, pathology and genetics","volume":"11","author":"Lacroix","year":"2004","journal-title":"Endocrine-related cancer."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-008-9952-1","article-title":"Patho-biological aspects of basal-like breast cancer","volume":"113","author":"Rakha","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1556\/oh.2009.28615","article-title":"Current status of treatment for early-stage invasive breast cancer","volume":"150","author":"K\u00e1sler","year":"2009","journal-title":"Orvosi hetilap."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.155.3.1151","article-title":"Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases","volume":"155","author":"Sakaguchi","year":"1995","journal-title":"J Immunol (Baltimore Md: 1950)."},{"key":"B7","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/nri821","article-title":"CD4+ CD25+ suppressor T cells: more questions than answers","volume":"2","author":"Shevach","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/nri1027","article-title":"Regulatory T cells in transplantation tolerance","volume":"3","author":"Wood","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/ni0901-816","article-title":"Regulatory T cells in the control of immune pathology","volume":"2","author":"Maloy","year":"2001","journal-title":"Nat Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2008.08.276","article-title":"CD8+ regulatory T cells, their suppressive mechanisms, and regulation in cancer","volume":"69","author":"Wang","year":"2008","journal-title":"Hum Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-06-2181","article-title":"Cutaneous T-cell lymphoma: Malignant proliferation of T-regulatory cells","volume":"105","author":"Berger","year":"2005","journal-title":"Blood."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.04999.x","article-title":"Expression of FoxP3, a key molecule in CD4CD25 regulatory T cells, in adult T-cell leukaemia\/lymphoma cells","volume":"126","author":"Karube","year":"2004","journal-title":"Br J haematology."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-008-0570-x","article-title":"Possible involvement of regulatory T cells in tumor onset and progression in primary breast cancer","volume":"58","author":"Ohara","year":"2009","journal-title":"Cancer immunology immunotherapy: CII."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.169.5.2756","article-title":"Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma","volume":"169","author":"Liyanage","year":"2002","journal-title":"J Immunol (Baltimore Md: 1950)."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-2347","article-title":"CD4+CD25+ regulatory T-cell frequency in HER-2\/neu (HER)-positive and HER-negative advanced-stage breast cancer patients","volume":"13","author":"Perez","year":"2007","journal-title":"Clin Cancer research: an Off J Am Assoc Cancer Res"},{"key":"B16","article-title":"Increase of regulatory T cells in the peripheral blood of cancer patients","volume":"9","author":"Wolf","year":"2003","journal-title":"Clin Cancer research: an Off J Am Assoc Cancer Res"},{"key":"B17","doi-asserted-by":"publisher","first-page":"296","DOI":"10.4103\/1008-682X.171582","article-title":"Bibliometrics: tracking research impact by selecting the appropriate metrics","volume":"18","author":"Agarwal","year":"2016","journal-title":"Asian J andrology."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0223994","article-title":"Visualizing a field of research: A methodology of systematic scientometric reviews","volume":"14","author":"Chen","year":"2019","journal-title":"PloS One"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0307513100","article-title":"Searching for intellectual turning points: progressive knowledge domain visualization","author":"Chen","year":"2004","journal-title":"Proc Natl Acad Sci United States America."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.joi.2017.08.007","article-title":"bibliometrix: An R-tool for comprehensive science mapping analysis","volume":"11","author":"Aria","year":"2017","journal-title":"J Informetrics."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s11192-009-0146-3","article-title":"Software survey: VOSviewer, a computer program for bibliometric mapping","volume":"84","author":"van Eck","year":"2010","journal-title":"Scientometrics."},{"key":"B22","first-page":"1","article-title":"Science mapping: A systematic review of the literature","volume":"2","author":"Chaomei","year":"2017","journal-title":"J Data Inf Science."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/nm1093","article-title":"Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival","volume":"10","author":"Curiel","year":"2004","journal-title":"Nat Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12967-019-1810-x","article-title":"Emerging trends and research foci in gastrointestinal microbiome","volume":"17","author":"Huang","year":"2019","journal-title":"J Trans Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.766248","article-title":"Research progress on the role of regulatory T cell in tumor microenvironment in the treatment of breast cancer","volume":"11","author":"Liu","year":"2021","journal-title":"Front Oncol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1038\/s41467-021-21297-y","article-title":"Common clonal origin of conventional T cells and induced regulatory T cells in breast cancer patients","volume":"12","author":"Xydia","year":"2021","journal-title":"Nat Commun"},{"key":"B27","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s00262-017-1964-4","article-title":"Tumor specific regulatory T cells in the bone marrow of breast cancer patients selectively upregulate the emigration receptor S1P1","volume":"66","author":"Rathinasamy","year":"2017","journal-title":"Cancer immunology immunotherapy: CII."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-011-1106-3","article-title":"Metronomic cyclophosphamide treatment in metastasized breast cancer patients: immunological effects and clinical outcome","volume":"61","author":"Ge","year":"2012","journal-title":"Cancer immunology immunotherapy: CII."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.20756","article-title":"Parity improves anti-tumor immunity in breast cancer patients","volume":"8","author":"Krause","year":"2017","journal-title":"Oncotarget."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1158\/2326-6066.CIR-18-0763","article-title":"Tumor-specific regulatory T cells from the bone marrow orchestrate antitumor immunity in breast cancer","volume":"7","author":"Ge","year":"2019","journal-title":"Cancer Immunol Res"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e24962","DOI":"10.4161\/onci.24962","article-title":"HLA Class II tetramers reveal tissue-specific regulatory T cells that suppress T-cell responses in breast carcinoma patients","volume":"2","author":"Schmidt","year":"2013","journal-title":"Oncoimmunology."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1097\/CCO.0b013e328331a78e","article-title":"Current developments with peptide-based human tumor vaccines","volume":"21","author":"Khazaie","year":"2009","journal-title":"Curr Opin Oncol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1172\/JCI39608","article-title":"Antigen-specific Tregs control T cell responses against a limited repertoire of tumor antigens in patients with colorectal carcinoma","volume":"119","author":"Bonertz","year":"2009","journal-title":"J Clin Invest"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2009.100","article-title":"Therapeutic immunity by adoptive tumor-primed CD4(+) T-cell transfer in combination with in vivo GITR ligation","volume":"17","author":"Liu","year":"2009","journal-title":"Mol therapy: J Am Soc Gene Ther"},{"key":"B35","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s12672-022-00482-5","article-title":"The ratio of CD8\u2009+\u2009lymphocytes to tumor-infiltrating suppressive FOXP3\u2009+\u2009effector regulatory T cells is associated with treatment response in invasive breast cancer","volume":"13","author":"Goda","year":"2022","journal-title":"Discover Oncol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1000496","article-title":"B7-H1-dependent sex-related differences in tumor immunity and immunotherapy responses","volume":"185","author":"Lin","year":"2010","journal-title":"J Immunol (Baltimore Md: 1950)."},{"key":"B37","doi-asserted-by":"publisher","first-page":"R47","DOI":"10.1186\/bcr2869","article-title":"Recruitment of regulatory T cells is correlated with hypoxia-induced CXCR4 expression, and is associated with poor prognosis in basal-like breast cancers","volume":"13","author":"Yan","year":"2011","journal-title":"Breast Cancer research: BCR."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.v127:4","article-title":"Regulatory T cells in tumor immunity","volume":"127","author":"Nishikawa","year":"2010","journal-title":"Int J cancer."},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-0050","article-title":"The Wilms\u2019 tumor antigen is a novel target for human CD4+ regulatory T cells: implications for immunotherapy","volume":"68","author":"Lehe","year":"2008","journal-title":"Cancer Res"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/nature10169","article-title":"Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T(reg) cells","volume":"475","author":"Facciabene","year":"2011","journal-title":"Nature."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2007.02.004","article-title":"Regulatory T cells and cancer","volume":"19","author":"Wang","year":"2007","journal-title":"Curr Opin Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0802664","article-title":"Tumor regulatory T cells potently abrogate antitumor immunity","volume":"182","author":"Liu","year":"2009","journal-title":"J Immunol (Baltimore Md: 1950)."}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2024.1448714\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T06:33:28Z","timestamp":1732689208000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2024.1448714\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,27]]},"references-count":42,"alternative-id":["10.3389\/fonc.2024.1448714"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2024.1448714","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,27]]},"article-number":"1448714"}}